UK Nail Fungus 'Acts Fast' Claim Survives On Late-Emerging Evidence
Executive Summary
UK agency says Vemedia Export supported Excilor nail fungus treatment claims with evidence including a study with more than 100 subjects that became available after Bayer challenged the Dutch firm's online advertising.
You may also be interested in...
FTC Stretched Standards In Enforcement Against Bayer Probiotic Claim
Judge Jose Linares states in his opinion that FTC’s requirement for “competent and reliable scientific evidence” to substantiate ad claims for consumer health care products aligns with FDA’s regulation of supplement claims under DSHEA, and Bayer complied with both agencies’ regs.
Ultrahuman Expands Wearable Medtech Production Into US After $35M Funding Round
Firm operating in London, India and United Arab Emirates says its “Ultra Factory” will open in Indiana within the next six months with end-to-end production based on its operational facility in India.
Ultrahuman Expands Wearable Medtech Production Into US After $35M Funding Round
Firm operating in London, India and United Arab Emirates says its “Ultra Factory” will open in Indiana within the next six months with end-to-end production based on its operational facility in India.